Counseling Intervention on Severe Nomophobia Among Health Care Providers

August 9, 2024 updated by: Sarah Ahmed Abdelmoaty, Cairo University

The Effect of a Counseling Intervention on Severe Nomophobia Among Health Care Providers: Randomized Controlled Clinical Trial

Assess the effect of a counseling intervention adopted from heath belief model merged with multiple smart phone-based action cues on the level of nomophobia among participants with severe nomophobia Assess the effect of a counseling intervention adopted from heath belief model merged with multiple smart phone-based action cues on the level of nomophobia among participants with severe nomophobia

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

In this study we seek to find if there is a relation between nomophobia level, self-esteem and mental health status, and discover whether a counseling intervention based on health belief model merged with smart phone-based action cues will decrease the level of nomophobia in participants with severe nomophobia.

through an intervention based on health belief model merged with multiple smart phone action cues employed on the intervention group during 3 counselling sessions

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11562
        • Faculty of Medicine- Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Owning and actively using a smartphone.
  • Understanding verbal English instructions.
  • Willing to participate in a possible counseling session
  • physicians currently working in kasr alainy hospital

Exclusion Criteria:

  • Having any diagnosed psychiatric disorder.
  • Participants taking medications that could affect psychological status e.g: B blockers, mood stabilizers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: counseling group
  1. assessement of nomophobia score, mental health and self-esteem scores.
  2. received 3 counselling sessions based on health belief model merged with smart phone action cues.
  3. assessment of nomophobia score, mental health and self-esteem scores post intervention
the counselling sessions were adopted from the health belief model with the cues of action depending on mobile phones as muting notifications, removing social media and using computers instead if possible.
No Intervention: control group
assessment of nomophobia score, mental health and self-esteem scores at the same time interval of the intervention group, pre and post intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study the effect of the counseling program on severe nomophobia score among participants in the intervention group.
Time Frame: 18 months
apply the counseling program and reassess the nomophobia level post-intervention by using the nomophobia questionnaire developed by Yildirim & Correia (2015). With a total of twenty statements on the questionnaire, responses were recorded on a 7-point Likert scale, with 7 representing strongly agree and 1 representing strongly disagree. The lack of nomophobia corresponded to a score of 20. Mild nomophobia was indicated by questionnaire scores ranging from 21 ≤ to < 60. On the other hand, scores between 60 and less than 100 suggested a moderate level of nomophobia, while scores between 100 and 140 indicated a severe level of nomophobia
18 months
Compare the level of nomophobia between intervention and control group post intervention.
Time Frame: 24 months
apply the counseling program and comparing the nomophobia score with the control group post intervention at same time frame, by using the nomophobia questionnaire developed by (Yildirim & Correia, 2015) where severe nomophobes are those with a score above 100, comparing the post counseling sessions score between the intervention or the control group whether there was a significant decline in the nomophobia score.
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
correlation between nomophobia scores, self-esteem scores and mental health scores
Time Frame: 18 months

pre and post intervention nomophobia scores using the nomophobia questionnaire were correlated to the self-esteem scores using state self esteem questionnaire with r value expressed to show whether the correlation is positive or negative and it's strength.

as well the nomophobia scores using nomophobia questionnaire were correlated to the mental health scores using the mental health inventory questionnaire, where positive r indicates positive correlation and negative r indicates an inverse correlation, the strength of the correlation is determined by the value of r.

18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: sarah A Abdelmoaty, master, Cairo university

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 28, 2023

Primary Completion (Actual)

July 1, 2024

Study Completion (Actual)

August 1, 2024

Study Registration Dates

First Submitted

August 3, 2024

First Submitted That Met QC Criteria

August 9, 2024

First Posted (Actual)

August 13, 2024

Study Record Updates

Last Update Posted (Actual)

August 13, 2024

Last Update Submitted That Met QC Criteria

August 9, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • nomophobia (MD-425-2022)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Specific Phobia, Other

Clinical Trials on counselling sessions

Subscribe